Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal Vaccination
Final Report: A Phase 3, Randomized, Open-Label Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Adults ≥65 Years of Age With Prior Pneumococcal Vaccination
Category & Conditions: Vaccine-related Conditions
Medicine: PF-06482077
ClinicalTrials.gov Identifier (NCT): NCT03835975
Protocol ID: B7471006
PrintDownloadOpen Plain Language Summary Result: Click here